Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?

Bone Marrow Transplantation volume 21, pages 641–650 (1998)Cite this article

Abstract

The use of blood and/or bone marrow stem cell transplantation (SCT) grew extensively in the last decade as technological advances led to improved outcomes and wider availability. The first study of SCT costs, however, was not published until 1989. This paper summarizes current knowledge about costs and cost-effectiveness of allogeneic and autologous SCT for leukemias and lymphoma. Methodological issues in cost studies such as types of costs, methods of data collection, and time horizons are discussed, and studies are evaluated with regard to these issues. Considerations specific to economic analyses of SCT are considered, including the potential impact of technological changes, learning curve effects, and inter-institutional differences.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Institute for Health Services Research and Policy Studies, Northwestern University, Evanston and Chicago, IL, USA

    TM Waters & CL Bennett

  2. Lurie Cancer Center, Northwestern University, Chicago, IL, USA

    TM Waters & CL Bennett

  3. Midwest Center for Health Services and Policy Research, Hines VA Hospital, Hines, IL, USA

    TM Waters

  4. Lakeside Division, Chicago VA Health System, Chicago, IL, USA

    CL Bennett & TS Pajeau

  5. Statistical Center of the International Bone Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry, and the Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI, USA

    KA Sobocinski, JP Klein, PA Rowlings & MM Horowitz

Authors
  1. TM Waters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. CL Bennett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. TS Pajeau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. KA Sobocinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. JP Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. PA Rowlings
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. MM Horowitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waters, T., Bennett, C., Pajeau, T. et al. Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?. Bone Marrow Transplant 21, 641–650 (1998). https://doi.org/10.1038/sj.bmt.1701160

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1701160

Keywords

This article is cited by

Search

Advanced search

Quick links